|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.59 SEK | -1.98% |
|
-5.52% | -26.24% |
| 11-03 | Dividend Forecasts for Swedish Companies - Humana Sees Largest Upward Revision This Month | FW |
| 10-30 | HUSQVARNA : Recharging the batteries | ![]() |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 6.64 | 7.55 | 5.35 | 5.16 | 3.42 | |||||
Return on Total Capital | 9.86 | 11.7 | 7.88 | 7.24 | 4.82 | |||||
Return On Equity % | 14.53 | 22.92 | 8.47 | 9.11 | 5.48 | |||||
Return on Common Equity | 14.53 | 22.93 | 8.48 | 9.11 | 5.48 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 31.45 | 33.11 | 30.02 | 31.64 | 30.43 | |||||
SG&A Margin | 20.62 | 20.99 | 21.12 | 22.4 | 23.96 | |||||
EBITDA Margin % | 13.96 | 15.03 | 11.91 | 12.55 | 10.14 | |||||
EBITA Margin % | 11.43 | 12.73 | 9.62 | 10.05 | 7.41 | |||||
EBIT Margin % | 10.83 | 12.11 | 8.91 | 9.24 | 6.47 | |||||
Income From Continuing Operations Margin % | 5.95 | 9.43 | 3.58 | 4.09 | 2.74 | |||||
Net Income Margin % | 5.95 | 9.43 | 3.58 | 4.09 | 2.74 | |||||
Net Avail. For Common Margin % | 5.95 | 9.43 | 3.58 | 4.09 | 2.74 | |||||
Normalized Net Income Margin | 6.3 | 7.27 | 5.06 | 4.66 | 2.99 | |||||
Levered Free Cash Flow Margin | 15.58 | 3.33 | -9.93 | 8.21 | 9.72 | |||||
Unlevered Free Cash Flow Margin | 16 | 3.62 | -9.44 | 8.74 | 10.83 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.98 | 1 | 0.96 | 0.89 | 0.85 | |||||
Fixed Assets Turnover | 5.27 | 5.65 | 5.82 | 5.69 | 5.24 | |||||
Receivables Turnover (Average Receivables) | 12.19 | 12.43 | 10.22 | 9.22 | 8.92 | |||||
Inventory Turnover (Average Inventory) | 2.78 | 2.64 | 2.25 | 1.98 | 2.16 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.52 | 1.17 | 1.37 | 1.45 | 1.61 | |||||
Quick Ratio | 0.7 | 0.37 | 0.42 | 0.4 | 0.54 | |||||
Operating Cash Flow to Current Liabilities | 0.58 | 0.3 | -0.08 | 0.38 | 0.44 | |||||
Days Sales Outstanding (Average Receivables) | 30.01 | 29.35 | 35.72 | 39.6 | 41.03 | |||||
Days Outstanding Inventory (Average Inventory) | 131.68 | 138.46 | 162.09 | 184.24 | 169.54 | |||||
Average Days Payable Outstanding | 59.06 | 60.17 | 59.58 | 67.21 | 68.87 | |||||
Cash Conversion Cycle (Average Days) | 102.64 | 107.64 | 138.23 | 156.63 | 141.7 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 67.03 | 49.74 | 82.86 | 72.55 | 62.66 | |||||
Total Debt / Total Capital | 40.13 | 33.22 | 45.31 | 42.04 | 38.52 | |||||
LT Debt/Equity | 45.48 | 23.8 | 44.29 | 42.03 | 47.38 | |||||
Long-Term Debt / Total Capital | 27.23 | 15.9 | 24.22 | 24.36 | 29.13 | |||||
Total Liabilities / Total Assets | 60.79 | 57.49 | 61.04 | 58.74 | 56.65 | |||||
EBIT / Interest Expense | 16.05 | 26.03 | 11.38 | 10.89 | 3.65 | |||||
EBITDA / Interest Expense | 22.22 | 34.34 | 16.48 | 16.28 | 6.53 | |||||
(EBITDA - Capex) / Interest Expense | 17.67 | 26.52 | 13.21 | 13.18 | 4.84 | |||||
Total Debt / EBITDA | 1.82 | 1.43 | 2.85 | 2.34 | 2.75 | |||||
Net Debt / EBITDA | 0.84 | 1.14 | 2.52 | 2.14 | 2.4 | |||||
Total Debt / (EBITDA - Capex) | 2.29 | 1.85 | 3.56 | 2.9 | 3.72 | |||||
Net Debt / (EBITDA - Capex) | 1.06 | 1.47 | 3.14 | 2.64 | 3.24 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -0.79 | 12.2 | 14.83 | -1.44 | -9.22 | |||||
Gross Profit, 1 Yr. Growth % | 4.07 | 18.09 | 4.15 | 3.86 | -12.68 | |||||
EBITDA, 1 Yr. Growth % | 17.6 | 20.81 | -8.91 | 3.79 | -26.43 | |||||
EBITA, 1 Yr. Growth % | 20.81 | 24.92 | -13.17 | 2.88 | -33 | |||||
EBIT, 1 Yr. Growth % | 22.42 | 25.49 | -15.58 | 2.26 | -36.45 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -1.31 | 77.84 | -56.43 | 12.57 | -39.06 | |||||
Net Income, 1 Yr. Growth % | -1.31 | 77.91 | -56.39 | 12.51 | -39.14 | |||||
Normalized Net Income, 1 Yr. Growth % | 33.06 | 29.33 | -20.05 | -9.25 | -41.65 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -1.54 | 77.7 | -56.27 | 12.72 | -39.37 | |||||
Accounts Receivable, 1 Yr. Growth % | -9.97 | 32.25 | 45.41 | -15.61 | 4.97 | |||||
Inventory, 1 Yr. Growth % | -10.36 | 44.23 | 38.13 | -11.32 | -19.63 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -10.06 | 21.06 | 3.46 | -1.76 | -0.83 | |||||
Total Assets, 1 Yr. Growth % | 3.66 | 17.01 | 21.04 | -6.53 | -1.4 | |||||
Tangible Book Value, 1 Yr. Growth % | 4.19 | 2.93 | 15.61 | 1.68 | -3.07 | |||||
Common Equity, 1 Yr. Growth % | -1.28 | 26.81 | 10.95 | -0.97 | 3.57 | |||||
Cash From Operations, 1 Yr. Growth % | 64.65 | -29.91 | -130.17 | -513.52 | -3.27 | |||||
Capital Expenditures, 1 Yr. Growth % | -17.83 | 33.31 | -19.38 | 1.38 | 3.93 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 262.12 | -76.05 | -443.71 | -181.49 | 16.27 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 220.71 | -74.64 | -400.44 | -191.25 | 12.31 | |||||
Dividend Per Share, 1 Yr. Growth % | 6.67 | 25 | 0 | 0 | -66.67 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 1.04 | 5.5 | 13.51 | 6.39 | -5.41 | |||||
Gross Profit, 2 Yr. CAGR % | 6.67 | 10.86 | 10.89 | 4.01 | -4.76 | |||||
EBITDA, 2 Yr. CAGR % | 15.87 | 19.19 | 4.87 | -2.77 | -12.71 | |||||
EBITA, 2 Yr. CAGR % | 18.51 | 22.85 | 4.15 | -5.48 | -16.98 | |||||
EBIT, 2 Yr. CAGR % | 19.71 | 23.95 | 2.93 | -7.08 | -19.38 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 43.42 | 32.48 | -11.98 | -29.97 | -17.18 | |||||
Net Income, 2 Yr. CAGR % | 43.45 | 32.51 | -11.92 | -29.95 | -17.25 | |||||
Normalized Net Income, 2 Yr. CAGR % | 25.4 | 31.18 | 1.69 | -14.82 | -27.23 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 43.24 | 32.28 | -11.85 | -29.79 | -17.33 | |||||
Accounts Receivable, 2 Yr. CAGR % | -5.03 | 9.11 | 38.67 | 10.78 | -5.88 | |||||
Inventory, 2 Yr. CAGR % | -6.29 | 13.7 | 41.15 | 10.68 | -15.57 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 10.39 | 4.35 | 11.92 | 0.82 | -1.3 | |||||
Total Assets, 2 Yr. CAGR % | 6.17 | 10.13 | 19.01 | 6.37 | -4 | |||||
Tangible Book Value, 2 Yr. CAGR % | 14 | 3.56 | 9.08 | 8.42 | -0.72 | |||||
Common Equity, 2 Yr. CAGR % | 3.23 | 11.89 | 18.62 | 4.82 | 1.28 | |||||
Cash From Operations, 2 Yr. CAGR % | 101.67 | 7.43 | -54.01 | 11.7 | 100 | |||||
Capital Expenditures, 2 Yr. CAGR % | -8.68 | 4.62 | 3.67 | -9.6 | 2.64 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 313.22 | -6.86 | -9.38 | 67.36 | -6.42 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 759.9 | -9.81 | -12.81 | 65.57 | 1.31 | |||||
Dividend Per Share, 2 Yr. CAGR % | 3.28 | 15.47 | 11.8 | 0 | -42.26 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 2.11 | 4.63 | 8.52 | 8.29 | 0.91 | |||||
Gross Profit, 3 Yr. CAGR % | 4.68 | 10.35 | 8.57 | 8.5 | -1.88 | |||||
EBITDA, 3 Yr. CAGR % | 6.74 | 17.49 | 8.95 | 4.51 | -11.47 | |||||
EBITA, 3 Yr. CAGR % | 6.75 | 20.61 | 9.43 | 3.72 | -15.73 | |||||
EBIT, 3 Yr. CAGR % | 6.83 | 21.61 | 9.05 | 2.71 | -18.13 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -2.11 | 54.08 | -8.56 | -4.46 | -33.14 | |||||
Net Income, 3 Yr. CAGR % | -2.05 | 54.12 | -8.51 | -4.43 | -33.16 | |||||
Normalized Net Income, 3 Yr. CAGR % | 9.2 | 26.69 | 11.22 | -2.1 | -24.91 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -1.99 | 53.92 | -8.54 | -4.32 | -33.14 | |||||
Accounts Receivable, 3 Yr. CAGR % | -1.47 | 6.06 | 20.07 | 17.52 | 8.81 | |||||
Inventory, 3 Yr. CAGR % | 0.7 | 8.2 | 21.32 | 20.89 | -0.52 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 9.08 | 13.84 | 4.05 | 7.16 | 0.27 | |||||
Total Assets, 3 Yr. CAGR % | 7.11 | 9.67 | 13.66 | 9.8 | 3.71 | |||||
Tangible Book Value, 3 Yr. CAGR % | 7.1 | 10.18 | 7.43 | 6.56 | 4.45 | |||||
Common Equity, 3 Yr. CAGR % | 2.88 | 10.56 | 11.57 | 11.69 | 4.4 | |||||
Cash From Operations, 3 Yr. CAGR % | 29.29 | 41.79 | -29.65 | -4.37 | 6.47 | |||||
Capital Expenditures, 3 Yr. CAGR % | -0.49 | 3.57 | -4.08 | 2.9 | -5.3 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 64.05 | 59.93 | 43.81 | -12.53 | 44.39 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 56.62 | 165.69 | 34.6 | -11.48 | 45.55 | |||||
Dividend Per Share, 3 Yr. CAGR % | 2.17 | 10.06 | 10.06 | 7.72 | -30.66 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 3.01 | 5.51 | 6.53 | 5.33 | 2.72 | |||||
Gross Profit, 5 Yr. CAGR % | 4.94 | 6.96 | 7.12 | 7.76 | 3.02 | |||||
EBITDA, 5 Yr. CAGR % | 8.78 | 11.26 | 5.99 | 8.91 | -0.3 | |||||
EBITA, 5 Yr. CAGR % | 9.14 | 12.21 | 5.7 | 9.4 | -2.01 | |||||
EBIT, 5 Yr. CAGR % | 8.86 | 12.08 | 5.25 | 9.2 | -3.36 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 5.73 | 16.09 | -6.19 | 12.4 | -12.11 | |||||
Net Income, 5 Yr. CAGR % | 5.78 | 16.14 | -6.12 | 12.43 | -12.11 | |||||
Normalized Net Income, 5 Yr. CAGR % | 9.76 | 14.1 | 6.13 | 8.09 | -6.14 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 5.81 | 16.13 | -6.06 | 12.44 | -12.16 | |||||
Accounts Receivable, 5 Yr. CAGR % | 0.84 | 5.55 | 12.96 | 7.92 | 8.93 | |||||
Inventory, 5 Yr. CAGR % | 4.43 | 8.86 | 15.26 | 9.18 | 4.94 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 10.28 | 10.76 | 10.21 | 8.44 | 1.88 | |||||
Total Assets, 5 Yr. CAGR % | 7.96 | 9.08 | 11.72 | 8.33 | 6.23 | |||||
Tangible Book Value, 5 Yr. CAGR % | 7.14 | 4.48 | 7.89 | 9.48 | 4.09 | |||||
Common Equity, 5 Yr. CAGR % | 5.52 | 8.57 | 8.91 | 8.23 | 7.33 | |||||
Cash From Operations, 5 Yr. CAGR % | 20.97 | 9.76 | -14.49 | 28.89 | 6.85 | |||||
Capital Expenditures, 5 Yr. CAGR % | 4.56 | 2.87 | 1.14 | -1.91 | -1.45 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 36.72 | 17.88 | 29.39 | 62.78 | 21.1 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 33.83 | 13.13 | 23.91 | 119.8 | 20.14 | |||||
Dividend Per Share, 5 Yr. CAGR % | 7.78 | 9 | 5.92 | 5.92 | -14.97 |
- Stock Market
- Equities
- HUSQ B Stock
- Financials Husqvarna AB
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















